Skip to main content
Climb Bio, Inc. logo

Climb Bio, Inc. — Investor Relations & Filings

Ticker · CLYM ISIN · US28658R1068 US Professional, scientific and technical activities
Filings indexed 273 across all filing types
Latest filing 2022-05-16 Interim / Quarterly Rep…
Country US United States of America
Listing US CLYM

About Climb Bio, Inc.

https://climbbio.com/

Climb Bio, Inc. is a clinical-stage biotechnology company that develops therapeutics for patients with immune-mediated diseases. The company's mission is to deliver high-impact, disease-modifying medicines, with a scientific approach centered on developing differentiated monoclonal antibodies. Its pipeline includes investigational therapies for diseases with limited therapeutic options, which are being advanced through clinical studies across multiple areas to evaluate their potential to improve patient outcomes.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2022
2022-05-16 English
8-K
Regulatory Filings
2022-05-16 English
NONE
Major Shareholding Notification
2022-05-04 English
8-K
Regulatory Filings
2022-04-25 English
DEFA14A
Regulatory Filings
2022-04-08 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.